GIA
REGN icon

Gargoyle Investment Advisor’s Regeneron Pharmaceuticals REGN Stock Holding History

Gargoyle Investment Advisor’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$283K Sell
754
-772
-51% -$260K 0.44% 82
2019
Q3 		$423K Hold
1,526
– – 0.53% 80
2019
Q2 		$478K Buy
1,526
+97
+7% +$32.3K 0.53% 85
2019
Q1 		$587K Buy
+1,429
New +$588K 0.56% 87

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Gargoyle Investment Advisor's REGN Position: Q4 2019 in Review

Gargoyle Investment Advisor reduced its Regeneron Pharmaceuticals (REGN) stake by 51% in Q4 2019, selling an estimated $260K and leaving 754 shares worth $283K. The position accounts for 0.44% of the portfolio, ranked #82.

Gargoyle Investment Advisor first reported a position in REGN in Q1 2019 and has held it in 4 quarters since. The position peaked at $587K in Q1 2019. 702 funds tracked by Wall St. Rank hold REGN as of Q4 2019.

  • Gargoyle Investment Advisor held 754 shares of Regeneron Pharmaceuticals worth $283K as of Q4 2019.
  • Gargoyle Investment Advisor sold 772 Regeneron Pharmaceuticals shares in Q4 2019, an estimated $260K.
  • Regeneron Pharmaceuticals made up 0.44% of Gargoyle Investment Advisor's portfolio in Q4 2019, its #82 holding.
  • Gargoyle Investment Advisor first reported a position in Regeneron Pharmaceuticals in Q1 2019 and has held it in 4 quarters since.
  • Gargoyle Investment Advisor's Regeneron Pharmaceuticals position peaked at $587K in Q1 2019.
  • 702 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2019.

Based on Gargoyle Investment Advisor's 13F filing for Q4 2019, filed 18 Feb 2020.